Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA: 600420)
China
· Delayed Price · Currency is CNY 10.44
-0.35 (-3.24%)
Sep 6, 2024, 3:00 PM CST
Shanghai Shyndec Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 6,454 | 5,973 | 6,148 | 4,284 | 3,720 | 5,164 | Upgrade
|
| Cash & Short-Term Investments | 6,454 | 5,973 | 6,148 | 4,284 | 3,720 | 5,164 | Upgrade
|
| Cash Growth | 11.25% | -2.86% | 43.51% | 15.18% | -27.97% | 34.92% | Upgrade
|
| Accounts Receivable | 1,801 | 2,051 | 2,656 | 3,048 | 2,602 | 1,764 | Upgrade
|
| Other Receivables | 92.41 | 84.07 | 92.85 | 96.91 | 108.01 | 113.24 | Upgrade
|
| Receivables | 1,893 | 2,135 | 2,748 | 3,144 | 2,710 | 1,877 | Upgrade
|
| Inventory | 2,274 | 2,280 | 2,440 | 3,072 | 3,281 | 2,318 | Upgrade
|
| Prepaid Expenses | - | 61.63 | 47.69 | 40.21 | 54.95 | 83.46 | Upgrade
|
| Other Current Assets | 771.61 | 207.49 | 300.4 | 345.15 | 396.54 | 233.58 | Upgrade
|
| Total Current Assets | 11,393 | 10,657 | 11,684 | 10,886 | 10,162 | 9,676 | Upgrade
|
| Property, Plant & Equipment | 5,671 | 5,885 | 6,246 | 6,511 | 6,409 | 6,248 | Upgrade
|
| Long-Term Investments | 384.82 | 1,431 | 376.22 | 370.77 | 382.29 | 192.42 | Upgrade
|
| Goodwill | 160.15 | 160.15 | 160.15 | 160.15 | 292.3 | 337.05 | Upgrade
|
| Other Intangible Assets | 562.23 | 511.18 | 517.08 | 549.09 | 524.58 | 533.66 | Upgrade
|
| Long-Term Deferred Tax Assets | 146.06 | 153.13 | 239.09 | 188.75 | 115.32 | 122.44 | Upgrade
|
| Long-Term Deferred Charges | 359.95 | 331.74 | 227.83 | 144.74 | 169.53 | 187.3 | Upgrade
|
| Other Long-Term Assets | 1,292 | 223.65 | 179.17 | 259.22 | 195.05 | 341.44 | Upgrade
|
| Total Assets | 19,969 | 19,352 | 19,630 | 19,070 | 18,250 | 17,638 | Upgrade
|
| Accounts Payable | 1,466 | 1,374 | 1,249 | 1,542 | 2,105 | 1,369 | Upgrade
|
| Accrued Expenses | 250.74 | 1,595 | 1,675 | 1,670 | 468.15 | 411.92 | Upgrade
|
| Short-Term Debt | 40.04 | 45.05 | 321.14 | 2,014 | 1,619 | 2,064 | Upgrade
|
| Current Portion of Long-Term Debt | 1,024 | - | 48.37 | 539.63 | 144.99 | 729.58 | Upgrade
|
| Current Portion of Leases | - | 10.6 | 9.86 | 40.13 | 49.4 | 185.29 | Upgrade
|
| Current Income Taxes Payable | 76.36 | 29.95 | 37.94 | 30.86 | 23.84 | 44.74 | Upgrade
|
| Current Unearned Revenue | 138.32 | 244.6 | 344.17 | 201.23 | 1,362 | - | Upgrade
|
| Other Current Liabilities | 1,640 | 480.59 | 509.97 | 804.25 | 422.99 | 1,687 | Upgrade
|
| Total Current Liabilities | 4,635 | 3,780 | 4,196 | 6,843 | 6,194 | 6,492 | Upgrade
|
| Long-Term Debt | - | 1,031 | 2,955 | 1,547 | 1,988 | 1,647 | Upgrade
|
| Long-Term Leases | 52.79 | 57.97 | 68.57 | 43 | 0.59 | 44.51 | Upgrade
|
| Long-Term Unearned Revenue | 115.16 | 122.8 | 138.01 | 140.33 | 167.03 | 169.18 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 77 | 22.15 | 119.55 | 126.19 | 80.31 | 81.44 | Upgrade
|
| Other Long-Term Liabilities | 0.52 | - | - | - | - | - | Upgrade
|
| Total Liabilities | 4,881 | 5,014 | 7,478 | 8,700 | 8,431 | 8,435 | Upgrade
|
| Common Stock | 1,341 | 1,341 | 1,172 | 1,027 | 1,027 | 1,027 | Upgrade
|
| Additional Paid-In Capital | 5,204 | 5,204 | 3,587 | 2,545 | 2,545 | 2,545 | Upgrade
|
| Retained Earnings | 6,429 | 5,845 | 5,287 | 4,762 | 4,300 | 3,757 | Upgrade
|
| Comprensive Income & Other | -1.2 | -1.09 | 259.34 | 258.88 | 258.63 | 258.63 | Upgrade
|
| Total Common Equity | 12,973 | 12,388 | 10,305 | 8,593 | 8,131 | 7,587 | Upgrade
|
| Minority Interest | 2,116 | 1,950 | 1,847 | 1,777 | 1,688 | 1,616 | Upgrade
|
| Shareholders' Equity | 15,088 | 14,338 | 12,153 | 10,370 | 9,819 | 9,203 | Upgrade
|
| Total Liabilities & Equity | 19,969 | 19,352 | 19,630 | 19,070 | 18,250 | 17,638 | Upgrade
|
| Total Debt | 1,117 | 1,145 | 3,403 | 4,184 | 3,802 | 4,671 | Upgrade
|
| Net Cash (Debt) | 5,337 | 4,828 | 2,745 | 99.84 | -82.31 | 493.4 | Upgrade
|
| Net Cash Growth | 14.44% | 75.90% | 2649.36% | - | - | -45.57% | Upgrade
|
| Net Cash Per Share | 3.98 | 3.79 | 2.37 | 0.08 | -0.07 | 0.43 | Upgrade
|
| Filing Date Shares Outstanding | 1,341 | 1,341 | 1,172 | 1,027 | 1,027 | 1,027 | Upgrade
|
| Total Common Shares Outstanding | 1,341 | 1,341 | 1,172 | 1,027 | 1,027 | 1,027 | Upgrade
|
| Working Capital | 6,757 | 6,877 | 7,489 | 4,044 | 3,968 | 3,185 | Upgrade
|
| Book Value Per Share | 9.67 | 9.24 | 8.57 | 8.11 | 7.92 | 7.39 | Upgrade
|
| Tangible Book Value | 12,250 | 11,717 | 9,628 | 7,884 | 7,314 | 6,717 | Upgrade
|
| Tangible Book Value Per Share | 9.13 | 8.74 | 7.99 | 7.42 | 7.12 | 6.54 | Upgrade
|
| Buildings | - | 4,472 | 3,945 | 3,874 | 3,712 | 3,577 | Upgrade
|
| Machinery | - | 8,370 | 8,184 | 7,920 | 7,428 | 6,762 | Upgrade
|
| Construction In Progress | - | 101.35 | 642.37 | 585.52 | 575.85 | 580.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.